NO20060890L - Anvendelse av calcitonin ved osteoartritt - Google Patents

Anvendelse av calcitonin ved osteoartritt

Info

Publication number
NO20060890L
NO20060890L NO20060890A NO20060890A NO20060890L NO 20060890 L NO20060890 L NO 20060890L NO 20060890 A NO20060890 A NO 20060890A NO 20060890 A NO20060890 A NO 20060890A NO 20060890 L NO20060890 L NO 20060890L
Authority
NO
Norway
Prior art keywords
calcitonin
osteoarthritis
Prior art date
Application number
NO20060890A
Other languages
English (en)
Other versions
NO330867B1 (no
Inventor
Moise Azria
Claus Christiansen
Simon David Baterman
Shoufeng Li
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34135096&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20060890(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20060890L publication Critical patent/NO20060890L/no
Publication of NO330867B1 publication Critical patent/NO330867B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20060890A 2003-07-23 2006-02-23 Farmasoytisk preparat omfattende kalsitonin NO330867B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48940003P 2003-07-23 2003-07-23
PCT/EP2004/008210 WO2005014031A1 (en) 2003-07-23 2004-07-22 Use of calcitonin in osteoarthritis

Publications (2)

Publication Number Publication Date
NO20060890L true NO20060890L (no) 2006-04-24
NO330867B1 NO330867B1 (no) 2011-08-01

Family

ID=34135096

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060890A NO330867B1 (no) 2003-07-23 2006-02-23 Farmasoytisk preparat omfattende kalsitonin

Country Status (23)

Country Link
US (3) US7749954B2 (no)
EP (2) EP1651249B1 (no)
JP (2) JP4716987B2 (no)
KR (1) KR101070036B1 (no)
CN (1) CN1856321B (no)
AU (2) AU2004262906B2 (no)
BR (1) BRPI0412265A (no)
CA (1) CA2532565C (no)
ES (2) ES2398237T3 (no)
HK (2) HK1152229A1 (no)
IL (2) IL173002A (no)
IS (1) IS8316A (no)
MA (1) MA27929A1 (no)
MX (1) MXPA06000807A (no)
NO (1) NO330867B1 (no)
NZ (1) NZ544645A (no)
PL (2) PL1651249T3 (no)
PT (2) PT1651249E (no)
RU (1) RU2368390C2 (no)
TN (1) TNSN06022A1 (no)
TW (1) TWI343816B (no)
WO (1) WO2005014031A1 (no)
ZA (1) ZA200600373B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04005080A (es) * 2004-05-27 2005-11-30 Aspid S A De C V Una composicion moduladora de la inflamacion articular cronica a base de colagena-polivinilpirrolidona.
PE20070548A1 (es) 2005-09-19 2007-07-12 Emisphere Tech Inc Formas cristalinas de la sal de di-sodio del acido n-(5-clorosaliciloil)-8-aminocaprilico
GB0522566D0 (en) * 2005-11-04 2005-12-14 Novartis Ag Organic compounds
KR20140053419A (ko) 2005-11-17 2014-05-07 노파르티스 아게 약제학적 조성물
WO2008027854A2 (en) 2006-08-31 2008-03-06 Novartis Ag Pharmaceutical compositions comprising hgh for oral delivery
CA2679782C (en) * 2007-03-02 2015-02-17 Novartis Ag Oral administration of a calcitonin
PT2460515T (pt) * 2007-08-09 2017-04-27 Novartis Ag Composições orais de calcitonina e suas aplicações
WO2009059188A1 (en) 2007-11-02 2009-05-07 Emisphere Technologies, Inc. Method of treating vitamin b12 deficiency
CN102123697B (zh) 2008-08-18 2015-06-10 安特拉贝欧有限公司 用于口服给予蛋白质的方法和组合物
WO2010103045A1 (en) * 2009-03-12 2010-09-16 Nordic Bioscience A/S Treatment of diabetes and metabolic syndrome
WO2011067283A1 (en) * 2009-12-01 2011-06-09 Novo Nordisk A/S Novel peptidyl alpha-hydroxyglycine alpha-amidating lyases
US20120071410A1 (en) 2010-09-21 2012-03-22 Unigene Laboratories Inc. Calcitonin products and therapies for treating inflammatory or degenerative diseases
PT3095484T (pt) 2011-11-02 2018-06-20 Keybioscience Ag Miméticas de calcitonina para tratar doenças e distúrbios
CA2854175A1 (en) 2011-11-02 2013-05-10 Keybioscience Ag Peptide analogs for treating diseases and disorders
US11549098B2 (en) * 2012-03-16 2023-01-10 Fertility Innovations Limited Processing of sperm cells
JP6639389B2 (ja) 2013-11-14 2020-02-05 キーバイオサイエンス・アクチエンゲゼルシャフト 疾患および障害を処置するためのカルシトニン模倣体
CN104095828A (zh) * 2014-07-29 2014-10-15 中国药科大学 一种降钙素口服肠溶组合物及其制备方法
GB201500263D0 (en) 2015-01-08 2015-02-25 Keybioscience Ag Calcitonin analogues for treating diseases and disorders
US9849125B1 (en) 2015-11-03 2017-12-26 Banner Lifie Sciences LLC Anti-overingestion dosage forms
GB201704429D0 (en) 2017-03-21 2017-05-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
GB201707955D0 (en) 2017-05-18 2017-07-05 Keybioscience Ag Dual amylin and calcitonin receptor agonists for treating diseases and disorders
US10335375B2 (en) 2017-05-30 2019-07-02 Patheon Softgels, Inc. Anti-overingestion abuse deterrent compositions
KR20190036903A (ko) 2017-09-28 2019-04-05 (주)휴럼 리트세노라이드를 유효성분으로 하는 염증과 골관절염에 대한 예방 및 치료용 약학 조성물
US11274158B2 (en) * 2018-01-30 2022-03-15 Flagship Pioneering Innovations V, Inc. Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators
CN108586601B (zh) * 2018-05-14 2021-07-27 四川大学 一种骨靶向性鲑鱼降钙素及其制备方法
GB201813677D0 (en) 2018-08-22 2018-10-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
GB201813678D0 (en) 2018-08-22 2018-10-03 Keybioscience Ag Acylated calcitonin mimetics
CN116325808B (zh) 2020-03-02 2023-12-22 奇跃公司 沉浸式音频平台

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US608618A (en) 1898-08-09 Thomas millen
HU203204B (en) 1987-09-15 1991-06-28 Sandoz Ag Process for producing suppository containing calcitonin and taurocholic acid
JP3501471B2 (ja) 1992-06-15 2004-03-02 旭化成ファーマ株式会社 カルシトニン類の安定化組成物および安定化法
US5681811A (en) 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
US6191105B1 (en) 1993-05-10 2001-02-20 Protein Delivery, Inc. Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
US5359030A (en) 1993-05-10 1994-10-25 Protein Delivery, Inc. Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
US5866536A (en) 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
GB9623205D0 (en) * 1996-11-07 1997-01-08 Eurand Int Novel pharmaceutical compositions
US5773647A (en) 1997-02-07 1998-06-30 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
CA2369591C (en) * 1999-04-05 2011-06-14 Emisphere Technologies, Inc. Disodium salts, monohydrate, and ethanol solvates
US6309633B1 (en) 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
US6380405B1 (en) 1999-09-13 2002-04-30 Nobex Corporation Taxane prodrugs
US6436990B1 (en) 1999-10-27 2002-08-20 Nobex Corporation 6-methoxy-2-naphthylacetic acid prodrugs
US20020012459A1 (en) 2000-06-22 2002-01-31 Chips Brain Co. Ltd. Method and apparatus for detecting stereo disparity in sequential parallel processing mode
DE60141520D1 (de) 2000-08-29 2010-04-22 Biocon Ltd 5-asa-derivate mit entzündungshemmender und antibiotischer wirkung und verfahren zur behandlung von krankheiten mit diesen derivaten
CN1520401A (zh) 2000-10-25 2004-08-11 ʷ��˿�������ȳ�ķ���޹�˾ 钙离子阻断化合物
US6479692B1 (en) 2001-05-02 2002-11-12 Nobex Corporation Methods of synthesizing acylanilides including bicalutamide and derivatives thereof
ATE443527T1 (de) 2001-08-17 2009-10-15 Novartis Pharma Gmbh 5-cnac zur oralen verabreichung von parathormonfragmenten

Also Published As

Publication number Publication date
JP4716987B2 (ja) 2011-07-06
MXPA06000807A (es) 2006-08-23
CA2532565C (en) 2012-05-08
HK1089935A1 (en) 2006-12-15
TNSN06022A1 (en) 2007-10-03
KR101070036B1 (ko) 2011-10-04
KR20060034298A (ko) 2006-04-21
IL173002A0 (en) 2006-06-11
WO2005014031A1 (en) 2005-02-17
US8765675B2 (en) 2014-07-01
NO330867B1 (no) 2011-08-01
JP2006528152A (ja) 2006-12-14
US20100278881A1 (en) 2010-11-04
RU2368390C2 (ru) 2009-09-27
IL227988A0 (en) 2013-09-30
EP2316473A1 (en) 2011-05-04
ES2436152T3 (es) 2013-12-27
MA27929A1 (fr) 2006-06-01
AU2008202879B2 (en) 2012-05-24
PL1651249T3 (pl) 2013-04-30
NZ544645A (en) 2009-04-30
CN1856321B (zh) 2012-10-03
ES2398237T3 (es) 2013-03-14
EP1651249B1 (en) 2012-09-12
IL227988A (en) 2016-10-31
TWI343816B (en) 2011-06-21
JP2011121987A (ja) 2011-06-23
IS8316A (is) 2006-02-21
EP1651249A1 (en) 2006-05-03
RU2006105479A (ru) 2007-09-10
AU2004262906B2 (en) 2008-04-03
CN1856321A (zh) 2006-11-01
BRPI0412265A (pt) 2006-09-05
EP2316473B1 (en) 2013-08-21
CA2532565A1 (en) 2005-02-17
AU2004262906A1 (en) 2005-02-17
HK1152229A1 (en) 2012-02-24
TW200518769A (en) 2005-06-16
PL2316473T3 (pl) 2014-05-30
IL173002A (en) 2013-09-30
PT2316473E (pt) 2013-09-20
PT1651249E (pt) 2012-12-21
US20060194722A1 (en) 2006-08-31
AU2008202879A1 (en) 2008-07-24
US20140271735A1 (en) 2014-09-18
ZA200600373B (en) 2007-01-31
US7749954B2 (en) 2010-07-06

Similar Documents

Publication Publication Date Title
NO20060890L (no) Anvendelse av calcitonin ved osteoartritt
FR2890544B1 (fr) Applicateur
ATE356618T1 (de) Gegen missbrauch gesicherte darreichungsform
ATE365545T1 (de) Gegen missbrauch gesicherte darreichungsform
EE05505B1 (et) Personaalne teraapiasektsioon
JP2006502186A5 (ja) β-グルカンの使用
DE602004000935D1 (de) Kosmetikapplikator
ATE399523T1 (de) Haarbehandlungszusammensetzung
DE50301987D1 (de) Auftraggerät
NO20041840L (no) Rosuvastatin ved predemente tilstander
DE602004004266D1 (de) Pulverspender
DE602004018153D1 (de) Elektrooptischer umsetzer von position in zahlen
FR2879924B1 (fr) Composition cosmetique amincissante
DE502004002729D1 (de) Labor-Pumpeinheit
AT6273U3 (de) Behälter
DOS2004000865S (es) Contenedor
SE0303588D0 (sv) Surface protection of exposed biological tissues
DOS2004000861S (es) Contenedor
ATA15712003A (de) Behälter
DE112004000634D2 (de) Behälter
FI20030507A (fi) Alustamateriaali
UA8892S (uk) Інтернет-картка
ITVR20040163A1 (it) Contenitore di valori corazzato
FR2879925B1 (fr) Composition cosmetique amincissante
FI20031279A0 (fi) Turvallinen Internet

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees